VMD Stock Overview
Provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for VMD from our risk checks.
Viemed Healthcare, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$10.45 |
| 52 Week High | CA$16.25 |
| 52 Week Low | CA$8.14 |
| Beta | 1.19 |
| 11 Month Change | -2.70% |
| 3 Month Change | 8.29% |
| 1 Year Change | 3.88% |
| 33 Year Change | 2.05% |
| 5 Year Change | 110.26% |
| Change since IPO | 335.42% |
Recent News & Updates
Recent updates
Is Viemed Healthcare (TSE:VMD) A Risky Investment?
Sep 13
The Returns On Capital At Viemed Healthcare (TSE:VMD) Don't Inspire Confidence
May 27Does Viemed Healthcare (TSE:VMD) Have A Healthy Balance Sheet?
Feb 18Does Viemed Healthcare (TSE:VMD) Have A Healthy Balance Sheet?
Oct 27Some Investors May Be Worried About Viemed Healthcare's (TSE:VMD) Returns On Capital
Jul 08Does This Valuation Of Viemed Healthcare, Inc. (TSE:VMD) Imply Investors Are Overpaying?
Mar 10These 4 Measures Indicate That Viemed Healthcare (TSE:VMD) Is Using Debt Reasonably Well
Dec 09Shareholders May Not Be So Generous With Viemed Healthcare, Inc.'s (TSE:VMD) CEO Compensation And Here's Why
Jun 04Viemed Healthcare (TSE:VMD) Could Easily Take On More Debt
May 18Viemed Healthcare, Inc.'s (TSE:VMD) Stock Is Going Strong: Is the Market Following Fundamentals?
Mar 03I Ran A Stock Scan For Earnings Growth And Viemed Healthcare (TSE:VMD) Passed With Ease
Feb 16Viemed Healthcare (TSE:VMD) Seems To Use Debt Rather Sparingly
Feb 03If You Had Bought Viemed Healthcare (TSE:VMD) Shares Three Years Ago You'd Have Earned 319% Returns
Jan 21
Did Viemed Healthcare, Inc. (TSE:VMD) Insiders Sell Shares?
Jan 08Should You Rely On Viemed Healthcare's (TSE:VMD) Earnings Growth?
Dec 22Declining Stock and Solid Fundamentals: Is The Market Wrong About Viemed Healthcare, Inc. (TSE:VMD)?
Nov 25Shareholder Returns
| VMD | CA Healthcare | CA Market | |
|---|---|---|---|
| 7D | 4.6% | 3.2% | 0.6% |
| 1Y | 3.9% | 38.5% | 21.5% |
Return vs Industry: VMD underperformed the Canadian Healthcare industry which returned 7.6% over the past year.
Return vs Market: VMD matched the Canadian Market which returned 4.2% over the past year.
Price Volatility
| VMD volatility | |
|---|---|
| VMD Average Weekly Movement | 6.9% |
| Healthcare Industry Average Movement | 3.3% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in CA Market | 17.6% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: VMD has not had significant price volatility in the past 3 months.
Volatility Over Time: VMD's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 988 | Casey Hoyt | www.viemed.com |
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME devices.
Viemed Healthcare, Inc. Fundamentals Summary
| VMD fundamental statistics | |
|---|---|
| Market cap | CA$311.76m |
| Earnings (TTM) | CA$12.20m |
| Revenue (TTM) | CA$225.10m |
33.0x
P/E Ratio1.8x
P/S RatioIs VMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VMD income statement (TTM) | |
|---|---|
| Revenue | US$169.78m |
| Cost of Revenue | US$66.21m |
| Gross Profit | US$103.57m |
| Other Expenses | US$94.36m |
| Earnings | US$9.20m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.24 |
| Gross Margin | 61.00% |
| Net Profit Margin | 5.42% |
| Debt/Equity Ratio | 9.1% |
How did VMD perform over the long term?
See historical performance and comparison